Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911).
By Michel Bolla, H. Van Poppel, L. Collette, P. V. van Cangh, K. Vekemans, L. D. Da Pozzo, Theo M. de Reijke, A. Verbaeys, J. Bosset, R. van Velthoven and 4 more. The Lancet, 2005
1,031 citations recorded by the source corpus.
Subfields: Pulmonary and Respiratory Medicine, Radiation
View Paper: https://www.semanticscholar.org/paper/3fa288c4496bc5a23229cc79c7f5347e017f8706
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. (2009, background): “Our results show, like two other randomized trials, a significant reduction of biochemical progression 5 years after adjuvant RT.7,8 However, our study differs from both other studies in two major points, namely the inclusion criteria (achieving an undetectable PSA after RP) and the incorporation of”